3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 19.60%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
STC:DBD's 3-Year ROIIC % is ranked better than 69.71% of 941
companies
in the Drug Manufacturers industry
Industry Median: 3.74
vs STC:DBD: 19.60
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year ROIIC % Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year ROIIC % Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year ROIIC % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a 3-Year ROIIC % of 19.60 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is near median its historical median of 21.44. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year ROIIC % has ranged from 7.03 to 29.79. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #285 out of 941 companies in the Drug Manufacturers industry, placing it in the top 30.3%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year ROIIC % too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current 3-Year ROIIC % of 19.60 is near median its 10-year median of 21.44. Over the past 10 years, this metric has ranged from a low of 7.03 to a high of 29.79. The Drug Manufacturers industry median 3-Year ROIIC % is 3.74. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 19.60 is 424.1% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #285 out of 941 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year ROIIC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #285 out of 941 companies for 3-Year ROIIC %. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median 3-Year ROIIC % is 3.74. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 19.60 is 424.1% above this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own 3-Year ROIIC % has ranged from 7.03 to 29.79 over the past decade. While the company's 10-year median is 21.44 vs. the industry median of 3.74, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.74, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current 3-Year ROIIC % of 19.60 is 424.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current 3-Year ROIIC % is 19.60, which is near median its own 10-year median of 21.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,313.07, compared to a current price of ₫51,400.00 — trading 1.7% below its estimated fair value. The current 3-Year ROIIC % is 19.60, which is near median its 10-year median of 21.44 and 424.1% above the Drug Manufacturers industry median of 3.74. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current 3-Year ROIIC % is 19.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued.
The current stock price of ₫51,400.00 is trading 1.7% below its estimated GF Value™ of ₫52,313.07.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
3-Year ROIIC %: 19.60 (near median its 10-year median of 21.44)
GF Value™: ₫52,313.07 vs. price of ₫51,400.00 (1.7% below fair value)
Industry Position: 424.1% above the Drug Manufacturers median (#285 of 941)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
83GF Score
Get the complete analysis for STC:DBD
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
